Are there any special concerns with regard to prophylaxis and treatment of bioterror-related infections in elderly patients?
Consensus statements for the management of bioterror-related illnesses contain specific recommendations for treatment in adults, children, pregnant women, and immunocompromised persons (certain infections only). The statements are silent on the management of elderly patients so it is assumed that they would be treated the same as adults. Astute clinicians should be aware that elderly patients are likely to have decreased renal function, co-morbid conditions, and to be taking multiple medications. Therefore, it will be important to recognize the potential for drug-drug interactions and to carefully monitor elderly patients for adverse drug reactions. Reference: White SR, Henretig FM, Dukes RG. Medical management of vulnerable populations and co-morbid conditions of victims of bioterrorism. Emerg Med Clin N Am 2002;20:365-92.
Related Questions
- Are there any specific medication safety concerns with regard to prophylaxis and treatment of bioterror-associated infections in children?
- How Many Newly Diagnosed HIV-Positive Patients Meet Criteria for Antiretroviral Treatment or Prophylaxis against Opportunistic Infections?
- Are there any special concerns with regard to prophylaxis and treatment of bioterror-related infections in elderly patients?
